Avidity Biosciences, Inc. - Common Stock (RNA)

Historical Holders from Q2 2020 to Q3 2025

Symbol
RNA on Nasdaq
CUSIP
05370A108
Type / Class
Equity / Common Stock
Shares outstanding
120M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
136M
Holdings value
$3.86B
% of all portfolios
0.006%
Grand Portfolio weight change
+0%
Number of holders
205
Number of buys
108
Number of sells
-111
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Avidity Biosciences, Inc. - Common Stock (RNA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 13% $399M 15.6M FMR LLC Mar 31, 2025
JANUS HENDERSON GROUP PLC 10.1% +6.67% $356M $19.7M 12.1M +5.85% JANUS HENDERSON GROUP PLC Jul 31, 2025
WELLINGTON MANAGEMENT GROUP LLP 8.1% $248M 9.68M Wellington Management Group LLP Mar 31, 2025
BlackRock, Inc. 7.5% $231M 9.04M BlackRock, Inc. Mar 31, 2025

Institutional Holders of Avidity Biosciences, Inc. - Common Stock (RNA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 15.6K $681K +$272K $43.57 3
2025 Q2 136M $3.86B +$69.7M $28.40 205
2025 Q1 133M $3.96B +$178M $29.52 218
2024 Q4 128M $3.71B -$47.5M $29.08 232
2024 Q3 125M $5.75B +$525M $45.93 239
2024 Q2 112M $4.57B +$938M $40.85 191
2024 Q1 89.2M $2.28B +$379M $25.52 155
2023 Q4 99.9K $904K -$576K $9.05 2
2023 Q3 5.22M $33.3M -$4.35M $6.38 14
2023 Q2 82.4M $914M +$45.8M $11.09 138
2023 Q1 75.9M $1.16B +$45.1M $15.35 136
2022 Q4 71.6M $1.59B +$415M $22.19 145
2022 Q3 53.4M $872M -$46.9M $16.33 116
2022 Q2 51.9M $754M +$37.2M $14.53 100
2022 Q1 46.9M $866M +$27.2M $18.47 93
2021 Q4 45.4M $1.08B +$3.61M $23.77 101
2021 Q3 44.4M $1.09B +$240M $24.63 109
2021 Q2 34.5M $852M +$17.4M $24.71 92
2021 Q1 33.9M $739M +$60.8M $21.81 97
2020 Q4 30.8M $787M +$74.4M $25.52 81
2020 Q3 27M $755M +$43.8M $28.15 66
2020 Q2 25.5M $702M +$701M $28.26 52